{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-098303","form_type":"8-K","ticker":"PAHC","cik":"0001069899","company_name":"PHIBRO ANIMAL HEALTH CORP","filed_at":"2023-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.070108+00:00","generated_at":"2026-06-10T23:44:58.284429+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Phibro Animal Health CFO Damian Finio resigns; Richard Johnson named interim CFO","bullets":["Damian Finio resigns as CFO effective September 29, 2023.","Richard G. Johnson, former CFO (2002-2020), appointed interim CFO effective September 30, 2023.","Johnson has served as Finance Advisor since 2020 and will assist with transition until a successor is found.","No family relationships or reportable transactions involving Johnson under Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-098303","json":"https://secwatch.observer/filing/0001104659-23-098303.json","markdown":"https://secwatch.observer/filing/0001104659-23-098303.md","text":"https://secwatch.observer/filing/0001104659-23-098303.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069899/000110465923098303/0001104659-23-098303-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069899/000110465923098303/tm2325537d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T23:44:58.284429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"576e40b5cc","claim":"Damian Finio departed as Chief Financial Officer at PHIBRO ANIMAL HEALTH CORP.","evidence_excerpt":"Damian Finio informed the Company that he will be resigning from his position as Chief Financial Officer of the Company effective September 29, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465923098303/0001104659-23-098303-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigning"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"75a9de9314","claim":"Richard G. Johnson changed role as Chief Financial Officer at PHIBRO ANIMAL HEALTH CORP.","evidence_excerpt":"Richard G. Johnson, the former Chief Financial Officer of the Company, who has been serving as a Finance Advisor to the Company since November 16, 2020, will assume the role of interim Chief Financial Officer until a successor to Mr. Finio is identified.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465923098303/0001104659-23-098303-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"assumed the role of interim Chief Financial Officer"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}